Search
Bristol-Myers Squibb Co
BMYAdd to Watchlist
54.000USD
-1.270-2.30%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
110.27BMarket Cap
15.12P/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Eliquis
14.44B
29.97%
Opdivo
10.29B
21.34%
Orencia
3.71B
7.69%
Revlimid
2.95B
6.12%
Yervoy
2.90B
6.02%
Other
13.91B
28.86%
By RegionUSD
Name
Revenue
Proportion
United States
33.28B
69.05%
International
13.83B
28.69%
other
1.09B
2.26%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Eliquis
14.44B
29.97%
Opdivo
10.29B
21.34%
Orencia
3.71B
7.69%
Revlimid
2.95B
6.12%
Yervoy
2.90B
6.02%
Other
13.91B
28.86%
